Applied Clinical Trials
June 01, 2009
A Closing Thought
0
0
Using predictive modeling to combat the challenges of study enrollment.
June 01, 2009
News
0
0
Thought leaders in the subject recruitment field come together to discuss current issues and potential solutions.
June 01, 2009
News
0
0
Hear from the first FDA liaison in the Office of International Programs.
June 01, 2009
Feature Article
0
0
New survey captures sponsors changing global usage of, and relationships with, CRO partners.
June 01, 2009
Feature Article
0
0
How simulation can help in the planning and implementation of adaptive clinical trials.
June 01, 2009
Feature Article
0
0
A probability sampling assessment by FDA takes a look at compliance in the medical device world.
June 01, 2009
Global News
0
0
The European intiative of involving elderly in clinical trials picks up the pace as challenges are addressed.
June 01, 2009
Feature Article
0
0
Undertaking clinical studies in this emerging region requires first overcoming natural barriers.
June 01, 2009
Feature Article
0
0
Knowing what you want from a CROs proposal will help make the most of the selection process.
June 01, 2009
View from Brussels
0
0
EMEA releases new guideline for studies in PTSD, as new figures depict a lagging EU.
June 01, 2009
eShowcase
0
0
The latest eclinical software in the clinical trials industry.
June 01, 2009
News
0
0
Learn what Applied Clinical Trial's readers told us in our annual reader's survey.
June 01, 2009
Technology Viewpoint
0
0
Highlights and insights from a recent gathering of thousands of health care professionals.
June 01, 2009
Community
0
0
Industry news focusing on the people and organizations who work in the clinical trials profession.
June 01, 2009
Special Report: Electronic Common Technical Document
0
0
Roundtable participants discuss challenges and successes with early eCTD implementation.
June 01, 2009
Feature Article
0
0
What managers must know and do to overcome regulatory challenges and avoid hiccups.
June 01, 2009
View from Washington
0
0
Agency officials and sponsors anticipate stiffer oversight of research operations and disclosure requirements.